These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15383555)

  • 1. Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis.
    Nelson GW; Martin MP; Gladman D; Wade J; Trowsdale J; Carrington M
    J Immunol; 2004 Oct; 173(7):4273-6. PubMed ID: 15383555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles.
    Martin MP; Nelson G; Lee JH; Pellett F; Gao X; Wade J; Wilson MJ; Trowsdale J; Gladman D; Carrington M
    J Immunol; 2002 Sep; 169(6):2818-22. PubMed ID: 12218090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis.
    Williams F; Meenagh A; Sleator C; Cook D; Fernandez-Vina M; Bowcock AM; Middleton D
    Hum Immunol; 2005 Jul; 66(7):836-41. PubMed ID: 16112031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands.
    Jennes W; Verheyden S; Demanet C; Adjé-Touré CA; Vuylsteke B; Nkengasong JN; Kestens L
    J Immunol; 2006 Nov; 177(10):6588-92. PubMed ID: 17082569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling KIR-HLA genotype disparities in type 1 diabetes.
    van der Slik AR; Alizadeh BZ; Koeleman BP; Roep BO; Giphart MJ
    Tissue Antigens; 2007 Apr; 69 Suppl 1():101-5. PubMed ID: 17445178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci.
    Carrington M; Wang S; Martin MP; Gao X; Schiffman M; Cheng J; Herrero R; Rodriguez AC; Kurman R; Mortel R; Schwartz P; Glass A; Hildesheim A
    J Exp Med; 2005 Apr; 201(7):1069-75. PubMed ID: 15809352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.
    Gao X; Jiao Y; Wang L; Liu X; Sun W; Cui B; Chen Z; Zhao Y
    Clin Immunol; 2010 Oct; 137(1):139-46. PubMed ID: 20643584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Killer-cell immunoglobulin-like receptor gene polymorphisms and susceptibility to psoriatic arthritis.
    Chandran V; Bull SB; Pellett FJ; Ayearst R; Pollock RA; Gladman DD
    Rheumatology (Oxford); 2014 Feb; 53(2):233-9. PubMed ID: 24185760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis.
    Karlsen TH; Boberg KM; Olsson M; Sun JY; Senitzer D; Bergquist A; Schrumpf E; Thorsby E; Lie BA
    J Hepatol; 2007 May; 46(5):899-906. PubMed ID: 17383044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.
    David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C
    J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans.
    Du Z; Gjertson DW; Reed EF; Rajalingam R
    Immunogenetics; 2007 Jan; 59(1):1-15. PubMed ID: 17103212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional modulation of expanded CD8+ synovial fluid T cells by NK cell receptor expression in HLA-B27-associated reactive arthritis.
    Dulphy N; Rabian C; Douay C; Flinois O; Laoussadi S; Kuipers J; Tamouza R; Charron D; Toubert A
    Int Immunol; 2002 May; 14(5):471-9. PubMed ID: 11978777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of KIR/HLA ligand combinations on immune responses in malignant melanoma.
    Naumova E; Mihaylova A; Ivanova M; Mihailova S
    Cancer Immunol Immunother; 2007 Jan; 56(1):95-100. PubMed ID: 16547704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.
    Yu J; Heller G; Chewning J; Kim S; Yokoyama WM; Hsu KC
    J Immunol; 2007 Nov; 179(9):5977-89. PubMed ID: 17947671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition.
    Winter CC; Gumperz JE; Parham P; Long EO; Wagtmann N
    J Immunol; 1998 Jul; 161(2):571-7. PubMed ID: 9670929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of HLA-Cw4 but not HLA-Cw6 by the NK cell receptor killer cell Ig-like receptor two-domain short tail number 4.
    Katz G; Markel G; Mizrahi S; Arnon TI; Mandelboim O
    J Immunol; 2001 Jun; 166(12):7260-7. PubMed ID: 11390475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function.
    Yawata M; Yawata N; Draghi M; Little AM; Partheniou F; Parham P
    J Exp Med; 2006 Mar; 203(3):633-45. PubMed ID: 16533882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of killer cell immunoglobulin-like receptor genotypes with microscopic polyangiitis.
    Miyashita R; Tsuchiya N; Yabe T; Kobayashi S; Hashimoto H; Ozaki S; Tokunaga K
    Arthritis Rheum; 2006 Mar; 54(3):992-7. PubMed ID: 16508981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of killer cell immunoglobulin-like receptor and human leucocyte antigen-Cw gene combinations with systemic lupus erythematosus.
    Hou Y; Zhang C; Xu D; Sun H
    Clin Exp Immunol; 2015 May; 180(2):250-4. PubMed ID: 25581336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia.
    Bernson E; Hallner A; Sander FE; Wilsson O; Werlenius O; Rydström A; Kiffin R; Brune M; Foà R; Aurelius J; Martner A; Hellstrand K; Thorén FB
    Leukemia; 2017 Dec; 31(12):2552-2559. PubMed ID: 28529313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.